Is using 6‑0 Vicryl (polyglactin 910) for a running subcuticular skin closure acceptable?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Using 6-0 Vicryl for Running Subcuticular Closure

Using 6-0 Vicryl (polyglactin 910) for running subcuticular skin closure is acceptable and supported by evidence, though it represents a finer gauge than the commonly studied 4-0 size. The technique itself—continuous subcuticular closure with absorbable material—is strongly recommended and dramatically reduces wound dehiscence compared to interrupted sutures. 1

Evidence Supporting Absorbable Subcuticular Technique

  • Continuous subcuticular sutures reduce superficial wound dehiscence by 92% (RR 0.08; 95% CI 0.02-0.35) compared to interrupted transcutaneous sutures that require removal. 2, 1

  • The dramatic reduction in dehiscence occurs because absorbable subcuticular sutures retain 50-75% of their original tensile strength after 1 week in situ, providing extended wound support during the critical healing period without requiring removal at 7-9 days. 2, 1

  • No significant difference exists in surgical site infection rates between continuous and interrupted techniques (RR 0.73; 95% CI 0.40-1.33), meaning the dehiscence benefit comes without increased infection risk. 2, 1

Vicryl Specifically: Standard vs Rapide

  • Standard Vicryl (polyglactin 910) is the appropriate choice for subcuticular closure, as it maintains tensile strength for the necessary healing period. 2, 1

  • Studies demonstrating the superiority of continuous subcuticular technique specifically used 4-0 polyglactin (Vicryl) and 4-0 poliglecaprone as the absorbable materials. 2

  • Vicryl Rapide should NOT be used for this purpose—it is a rapidly absorbable suture appropriate only for superficial skin closure where minimal tensile strength is needed, not for subcuticular technique requiring sustained support. 1

Gauge Considerations: 6-0 vs 4-0

  • The published evidence base primarily studied 4-0 polyglactin for abdominal and body wounds. 2, 1

  • For facial wounds, 5-0 or 6-0 gauges are standard and have been studied with comparable infection and cosmetic outcomes. 3, 4

  • Using 6-0 Vicryl for body wounds represents a finer gauge than typically studied, but the principles remain sound: the continuous subcuticular technique with slowly absorbable material is what drives the clinical benefit, not the specific gauge. 1

Monofilament vs Multifilament Considerations

  • Vicryl is a braided multifilament suture, which theoretically carries higher bacterial seeding risk than monofilament alternatives like Monocryl (poliglecaprone). 1, 3

  • However, clinical data show no significant difference in infection rates between 4-0 Vicryl and 4-0 Monocryl for subcuticular closure (6.1% vs 5.1%; P = 0.58; adjusted OR 1.23; 95% CI 0.60-2.49). 5

  • In clean surgical wounds, both materials perform equivalently for infection risk and wound complications. 5, 6

  • For contaminated or high-risk wounds, prefer monofilament sutures or triclosan-coated Vicryl, which reduce surgical site infection (OR 0.72; 95% CI 0.59-0.88). 1

Critical Pitfalls to Avoid

  • Never use Vicryl Rapide for running subcuticular closure—its rapid absorption (42-56 days with loss of tensile strength much earlier) makes it unsuitable for wounds requiring sustained support. 1

  • Avoid pulling continuous sutures too tightly, as this strangulates wound edges, causes tissue ischemia, and paradoxically increases dehiscence risk. 1

  • Do not use rapidly absorbable sutures for fascial or deep closure—they are appropriate only for skin approximation where minimal tensile strength is required. 1

  • Ensure the suture-to-wound length ratio is at least 4:1 when closing fascia, though this is less critical for skin closure alone. 1

Practical Algorithm for Suture Selection

For clean wounds (body/extremity):

  • First choice: 4-0 Monocryl (monofilament) continuous subcuticular 1
  • Acceptable alternative: 4-0 or 6-0 Vicryl (multifilament) continuous subcuticular 2, 5

For facial wounds:

  • First choice: 5-0 or 6-0 monofilament non-absorbable (nylon/polypropylene) with removal at 5-7 days 3
  • Acceptable alternative when follow-up problematic: 5-0 or 6-0 Monocryl or Vicryl continuous subcuticular 3, 4

For contaminated/high-risk wounds:

  • Mandatory: Monofilament suture (Monocryl) OR triclosan-coated Vicryl 1
  • Avoid: Standard multifilament Vicryl without antimicrobial coating 1

Bottom Line

Your choice of 6-0 Vicryl for running subcuticular closure is clinically acceptable, particularly for smaller wounds or facial applications where finer gauge is appropriate. The continuous subcuticular technique itself provides the major clinical benefit of reducing dehiscence by 92%. 2, 1 While 4-0 gauge has more published evidence for body wounds and monofilament material has theoretical advantages, clinical outcomes with standard Vicryl are equivalent in clean surgical settings. 5

References

Guideline

Wound Closure Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Facial Laceration Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Comparison of suture materials for subcuticular skin closure at cesarean delivery.

American journal of obstetrics and gynecology, 2016

Research

Subcuticular Prolene or PDS for skin closure?

Journal of the Royal College of Surgeons of Edinburgh, 1991

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.